Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Faris Tamimi"'
Autor:
Hikmat Abdel-Razeq, Faris Tamimi, Sereen Iweir, Baha Sharaf, Sarah Abdel-Razeq, Osama Salama, Sarah Edaily, Hira Bani Hani, Khansa Azzam, Haneen Abaza
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Genetic counseling and testing are more accessible than ever due to reduced costs, expanding indications and public awareness. Nonetheless, many patients missed the opportunity of genetic counseling and testing due to barriers that existed a
Externí odkaz:
https://doaj.org/article/46ef5b3ed4414fc3ac84c1c1dd8db0be
Autor:
Hikmat Abdel-Razeq, Hira Bani Hani, Baha Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Publikováno v:
Cancers, Vol 16, Iss 14, p 2543 (2024)
Most of endometrial cancers are sporadic, with 5% or less being attributed to inherited pathogenic germline mutations and mostly related to the Lynch syndrome. To our knowledge, this is the first study to investigate patterns and frequencies of germl
Externí odkaz:
https://doaj.org/article/9a13668b701040bc8ea23709ac8f9e60
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24793- (2024)
Background: The absolute and relative benefits of adjuvant bisphosphonates on disease-free survival and overall survival in patients receiving contemporary systemic therapy for early breast cancer is uncertain. Methods: Data from randomized trials of
Externí odkaz:
https://doaj.org/article/92f7842d0bd34ce59dce826ac65b6a3a
Autor:
Consolacion Molto, Ariadna Tibau, Aida Bujosa, Jose Carlos Tapia, Abhenil Mittal, Faris Tamimi, Eitan Amir
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Little is known about the impact of control group therapy on clinical benefit scales such as American Society of Clinical Oncology Value Framework (ASCO-VF), European Society for Medical Oncology Magnitude Clinical Benefit Scale (ESMO-MCBS),
Externí odkaz:
https://doaj.org/article/4fa9188644864211aa9665663302eecc
Autor:
Jorge Bartolome, Consolacion Molto, Javier David Benitez-Fuentes, Gonzalo Fernandez-Hinojal, Aranzazu Manzano, Pedro Perez-Segura, Abhenil Mittal, Faris Tamimi, Eitan Amir, Alberto Ocana
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionIdentification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a key goal in cancer research. An example is the human leukocyte antigen G (HLA-G), a nonclassical ma
Externí odkaz:
https://doaj.org/article/dd488eb0aeb047e5a91a68274cb6c4d3
Autor:
Hikmat Abdel-Razeq, Faris Tamimi, Mohammed J. Al-Jaghbeer, Baha’ Sharaf, Rashid Abdel-Razeq, Jafar Bani Issa, Hala Abu-Jaish, Osama Salama
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 23, p 7209 (2023)
Background: Inferior vena cava (IVC) filters serve as a vital intervention when systemic anticoagulation proves ineffective or contraindicated, particularly in the context of cancer patients. This study aimed to provide real-world insights into the o
Externí odkaz:
https://doaj.org/article/e47e5787c639472484d12929c00d819a
Autor:
Abhenil Mittal, Consolacion Molto Valiente, Faris Tamimi, Ilana Schlam, Sarah Sammons, Sara M. Tolaney, Paolo Tarantino
Publikováno v:
Cancers, Vol 15, Iss 7, p 2015 (2023)
The rise of cyclin-dependent kinase (CDK)4/6 inhibitors has rapidly reshaped treatment algorithms for hormone receptor (HR)-positive metastatic breast cancer, with endocrine treatment (ET) plus a CDK4/6-inhibitor currently representing the standard o
Externí odkaz:
https://doaj.org/article/1c5b50fd9bff45e9b71c0b003063f8ab
Autor:
Hikmat Abdel-Razeq, Faris Tamimi, Lama Abujamous, Rashid Abdel-Razeq, Mahmoud Abunasser, Sara Edaily, Hazem Abdulelah, Razan Abu Khashabeh, Rayan Bater
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeContrary to BRCA pathogenic variants, recommendations for management of variants of uncertain significance (VUS) are not clear and focus more on the patient’s family and personal history of cancer. Local and regional data on VUS are scarce.
Externí odkaz:
https://doaj.org/article/ea91f14004fc4796ac5915fe979df101
Autor:
Samer Salah, Ramiz Abu‐Hijlih, Fawzi Abuhijla, Faris Tamimi, Abdallah Al‐Tell, Mohammed Shahait
Publikováno v:
Cancer Reports, Vol 4, Iss 5, Pp n/a-n/a (2021)
Abstract Background Although the prognostic role of neutrophil‐to‐lymphocyte ratio (NLR) has been assessed in patients with metastatic castration‐resistant prostate cancer, data on its impact on oncological outcomes of patients with metastatic
Externí odkaz:
https://doaj.org/article/cef483e2cf6c463ab0301b64601e5757
Autor:
Hikmat Abdel-Razeq MD, Faris Tamimi MD, Rashid Abdel-Razeq MD, Samer Salah MD, Zaid Omari MD, Osama Salama MD, Alaa Abufara MD, Abdalla Al-Tell MD, Hanna Qahoush MD, Ahmad Nasman MD, Ayat Taqash BSc, Yazan Alhalaseh MD, Rayan Bater MSc
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Malignancy, including testicular tumors, significantly increases the risk of venous thromboembolism (VTE). In this study, we search for predictors that may help identify subgroups of patients at higher risk of VTE. Patients with confirmed diagnosis o
Externí odkaz:
https://doaj.org/article/cd9425fd9dda487d837d3dcfb8bc3475